AstraZeneca (AZN), Espress Scripts (ESRX) Announce First D-T-P Program for ARIMIDEX Patients
Up)
AstraZeneca (NYSE: AZN) today announced its first-ever direct-to-patient program offering patients with a valid prescription for ARIMIDEX or anastrozole the opportunity to have the brand ARIMIDEX delivered directly to their home by Express Scripts (Nasdaq: ESRX), a specialty pharmacy services provider, for $40 per month, including shipping.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Royalty Pharma Raises $600 Million of Debt
- Apple (AAPL) Amends RSU Award Agreements in Lieu of Upcoming Dividend; CEO Cook Defers
- Auxilium (AUXL) Files Suit Against Watson (WPI) Over Testim 1% Gel
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
